Abstract
Botulinum neurotoxin type A (BoNT/A) is the potent disease agent in botulism, a potential biological weapon and an effective therapeutic drug for involuntary muscle disorders. The crystal structure of the entire 1,285 amino acid di-chain neurotoxin was determined at 3.3 Å resolution. The structure reveals that the translocation domain contains a central pair of αhelices 105 Å long and a ~50 residue loop or belt that wraps around the catalytic domain. This belt partially occludes a large channel leading to a buried, negative active site — a feature that calls for radically different inhibitor design strategies from those currently used. The fold of the translocation domain suggests a mechanism of pore formation different from other toxins. Lastly, the toxin appears as a hybrid of varied structural motifs and suggests a modular assembly of functional subunits to yield pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Montecucco, C. & Schiavo, G. Structure and function of tetanus and botulinum neurotoxins.Quarterly Rev. Biophys. 28, 423–472 (1995).
Krieglstein, K. G., DasGupta, B. R. & Henschen, A. H. Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains. J. Prot. Chem. 13, 49–57 (1994).
Simpson, L. L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J.Pharmacol. Exp. Ther. 212, 16–21 (1980).
Umland, T. C. et al. Structure of the receptor binding fragment Hc of tetanus neurotoxin . Nature Struct. Biol. 4, 788– 792 (1997).
Nishiki, T. et al The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 378, 253–257 (1996).
Montecucco, C. How do tetanus and botulinum toxins bind to neuronal membranes? TIBS 11, 314–317 ( 1986).
Shapiro, R. E. et al. Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand. J. Biol. Chem. 272, 30380–30386 ( 1997).
Holm, L. & Sander, C. The FSSP database of structurally aligned protein fold families. Nucleic Acids Res. 22 , 3600–3609 (1994).
Li, J. D., Carroll, J. & Ellar, D. J. Crystal structure of insecticidal delta-endotoxin from Bacillus thuringiensis at 2.5 Å resolution. Nature 353, 815–821 ( 1991).
Choe, S. et al.The crystal structure of diphtheria toxin. Nature 357, 216–222 (1992).
Parker, M. W., Pattus, F., Tucker, A. D. & Tsernoglou, D. Structure of the membrane-pore-forming fragment of colicin A. Nature 337, 93–96 ( 1989).
Allured, V. S., Collier, R. J., Carroll S. F. & McKay, D. B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution . Proc. Natl. Acad. Sci. U. S. A. 83, 1320 –1324 (1986).
Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 (1996).
Parker, M. W. & Pattus, F. Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. Trends Biochem. Sci. 18, 391–395 (1993).
Wiener, M., Freymann, D., Ghosh, FNM> & Stroud, R. M. Crystal structure of colicin 1a. Nature 385, 461– 464 (1997).
Harrison, C. J., Hayer-Hartl, M., Di Liberto, M., Hartl, F. & Kuriyan, J. Crystal structure of the nucleotide exchange factor GrpE bound to the ATPase domain of the molecular chaperone DnaK. Science 276, 431– 435 (1997).
Oblatt-Montal, M., Yamazaki, M., Nelson, R. & Montal, M. Formation of ion channels in lipid bilayers by a peptide with the predicted transmembrane sequence of botulinum neurotoxin A. Protein Science 4, 1490–1497 (1995).
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426– 430 (1997).
Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37–43 ( 1994).
Fass, D., Harrison, S. C. & Kim, P. S. Retrovirus envelope domain at 1.7 Å resolution . Nature Struct. Biol . 3, 465– 469 (1996).
Lebeda, F.J. & Olson, M.A. Secondary sturctural predictions for the clostridial neurotoxins. Proteins: Struct. Funct. Genet. 20, 293–300 ( 1994).
Yamasaki, S. et al. Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc. Natl. Acad. Sci. USA 91, 4688–4692 ( 1994).
Woody, M. & DasGupta, B. R. Effect of tetranitromethane on the biological activities of botulinum neurotoxin types A, B, and E. Mol. Cell. Biochem. 85, 159–169 (1989).
Morante, S. et al. X-ray absorption spectroscopy study of zinc coordination in tetanus neurotoxin, astacin, alkaline protease and thermolysin. Eur. J. Biochem. 235, 606–612 (1996).
Schmidt, J. J. & Bostian, K. A. Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin. J. Protein Chem. 16, 19–26 (1997).
Rossetto, O. et al. The metallo-proteinase activity of tetanus and botulinum neurotoxins . J. Physiology (Paris) 89, 43– 50 (1995).
Schmidt, J. J. & Bostian, K. A. Proteolysis of synthetic peptides by type A botulinum neurotoxin. J. Protein Chem. 14, 703–708 ( 1995).
Stevens, R. C., Evenson, M. L., Tepp, W. & DasGupta, B. R. Crystallization and preliminary x-ray analysis of botulinum neurotoxin type A. J. Mol. Biol. 222, 877–880 (1991).
Otwinowski, Z., in Data Collection and Processing, (eds Sawyer, L., Isaacs, N. & Bailey, S.) 56–62 (Science and Engineering Research Council, Warrington, UK; 1993).
CCP4: A Suite of Programs for Protein Crystallography (SERC Daresbury Laboratory, Warrington WA4 4AD, UK; 1979).
McRee, D. E. A visual protein crystallographic software system for X11/Xview J. Mol. Graphics 10, 44 (1992 ).
Cowtan, K. Joint CCP4 ESF-EACBM Newsl. Protein Crystallogr. 31, 34 (1994).
Jones, T. A., Zou, J.-Y, Cowan, S. W. & Kjelgaard, M. Improved methods for the building of protein models in electron density maps and the location of errors in these. Acta Crystallogr. A47, 110–119 (1991).
Read, R. J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. 42, 140– 149 (1986).
Brünger, A.T., X-PLOR v3.8 (Yale University Press, New Haven, CT; 1996).
Kraulis, P. J. MOLSCRIPT- a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946 –950 (1991).
Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11, 281–296 (1991).
Acknowledgements
We thank M. Evenson, B. Santarsiero, B. Spiller and G. Wedemayer for their help in the project, P. Kuhn and M. Soltis for their assistance at beamlines 7-1 and 9-1 at the Stanford Synchrotron Radiation Laboratory, R. Sweet at beamline X12C of the Brookhaven National Laboratory, T. Earnest at the Advanced Light Source, F. Lebeda for helpful discussions, and T. Umland for providing us with the tetanus toxin binding domain coordinates. Financial support for this research was provided by a NSF pre-doctoral fellowship (D.B.L.) and the US Army Medical Research Institute of Infectious Diseases.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lacy, D., Tepp, W., Cohen, A. et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Mol Biol 5, 898–902 (1998). https://doi.org/10.1038/2338
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/2338
This article is cited by
-
Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
Nature Communications (2023)
-
A human bispecific antibody neutralizes botulinum neurotoxin serotype A
Scientific Reports (2023)
-
A DARPin promotes faster onset of botulinum neurotoxin A1 action
Nature Communications (2023)
-
Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid
Scientific Reports (2022)
-
Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay
Scientific Reports (2021)